Argatroban
-
- Applikation
- Inhibition Assay (InhA), Functional Studies (Func)
- Verwendungszweck
- Argatroban is a direct, selective thrombin inhibitor. The American College of Cardiologists (ACC) recommend using bivalirudin or argatroban in patients who have had, or at risk for, heparin induced thrombocytopenia (HIT) and are undergoing percutaneous coronary intervention. Argatroban is a non-heparin anticoagulant shown to both normalize platelet count in patients with HIT and prevent the formation of thrombi. Parental anticoagulants must be stopped and a baseline activated partial thromboplastin time must be obtained prior to administering argatroban.
- Produktmerkmale
-
Tradename: Argatroban
Source of Compound: synthetic
Target: Prothrombin inhibitor
Receptor: Prothrombin
- Aufreinigung
- All the products are sent with COA, HPLC and NMR inspection report to guarantee the quality.
- Reinheit
- 99 %
- Formel
- C23H36N6O5S
- Löslichkeit
- DMSO 9 mg/mL,Ethanol 6 mg/mL
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Solid
- Lagerung
- -20 °C
- Informationen zur Lagerung
-
For the majority of compounds, they could be dissolved in DMSO or other organic solvent.
Their stock solution can be stored at -20°C for up to 3 months and aliquoted for sampling convenience.
Several freeze/thaw cycles should not damage the activity of our small molecule products.
However, in many instances the aqueous solutions of some compounds need to be made fresh and cannot be stored. For these compounds, their solution should be prepared just before use and stored no longer than 24 hours. - Haltbarkeit
- 24 months
-
- Hintergrund
- Angiogenesis
- Molekulargewicht
- 508.63 g/mol
- CAS-Nummer
- 74863-84-6
-